KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Accumulated Expenses (2018 - 2026)

Twist Bioscience has reported Accumulated Expenses over the past 9 years, most recently at $27.0 million for Q1 2026.

  • Quarterly Accumulated Expenses rose 8.36% to $27.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $27.0 million through Mar 2026, up 8.36% year-over-year, with the annual reading at $31.3 million for FY2025, 107.15% up from the prior year.
  • Accumulated Expenses was $27.0 million for Q1 2026 at Twist Bioscience, up from $18.8 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $31.7 million in Q2 2024 and troughed at $10.3 million in Q2 2023.
  • The 5-year median for Accumulated Expenses is $24.3 million (2023), against an average of $22.1 million.
  • Year-over-year, Accumulated Expenses soared 469.1% in 2022 and then tumbled 62.77% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $23.3 million in 2022, then crashed by 40.03% to $14.0 million in 2023, then soared by 44.2% to $20.1 million in 2024, then decreased by 6.43% to $18.8 million in 2025, then skyrocketed by 43.37% to $27.0 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Accumulated Expenses are $27.0 million (Q1 2026), $18.8 million (Q4 2025), and $31.3 million (Q3 2025).